LQDA (Liquidia Corporation) Earnings per share growth rate in current year

Official company branding of Liquidia Corporation (LQDA)

Liquidia Corporation (LQDA) relies on the stability of external manufacturing, where any logistical disruptions threaten the production of orphan drugs. Military conflicts are hindering lung drug trials and aerosol synthesis. Business success is tied to patent disputes and regulators rather than macro cycles. The current year-over-year EPS trend illustrates the issuer's viability, with the parameter stabilizing at 84.50.

LQDA (Liquidia Corp) Earnings per share growth in current year history from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company liquidia.com (LQDA)

- business market valuation indicators:
Summary company analysis:Liquidia Corporation
Mass-produced product of Liquidia Corporation

For Liquidia Corporation (LQDA), which is focused on drug commercialization and the refinement of inhalation systems amid patent disputes, annual EPS fluctuations serve as an indicator of operational efficiency. This metric measures the year-over-year percentage change in earnings per share, capturing the business's ability to generate income against a backdrop of inflation, which allows investors to assess the fundamental stability and asset quality of the company.

Direct competitors

Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|GLPG - Earnings growth in current year|ANIP: Earnings growth in current year|Earnings per share growth this year MNKD|AMPH (Amphastar) - Earnings growth in current year|Pacira Corp (PCRX) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|Earnings growth in current year Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year SCPH|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals